Corvex Secures Long-Term Nvidia GPU Lease to Boost AI Development
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jan 23 2026
0mins
Source: stocktwits
- Long-Term GPU Lease: Corvex has signed a long-term lease agreement with a leading high-performance battery technology provider to deploy a cluster of Nvidia H200 GPUs for AI research and development, significantly enhancing its AI platform's competitiveness and accelerating the merger with Movano.
- Secure Enterprise AI Workloads: Corvex is providing a managed on-premise solution that utilizes hardware encryption and remote attestation to ensure data sovereignty and compliance, thereby enhancing the customer's ability to extend AI workloads into security-sensitive environments.
- Kubernetes Platform Management: The company offers a fully managed Kubernetes platform designed to automate resource scheduling, improve GPU utilization, and reduce idle capacity, supporting large-scale model training and production inference to optimize operational efficiency.
- Positive Market Reaction: Movano's stock surged over 70% in premarket trading following Corvex's GPU lease announcement, reflecting strong market optimism regarding the merger and the future of the AI infrastructure platform.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy MOVE?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on MOVE
About MOVE
Movano Inc., doing business as Movano Health, is developing a platform to deliver purpose-driven healthcare solutions to bring medical-grade data to the forefront of consumer health devices. Its commercial product Evie Ring is a wearable designed specifically for women. The Evie Ring combines health and wellness metrics to give a full picture of one’s health, which includes resting heart rate, heart rate variability, blood oxygen saturation, respiration rate, skin temperature variability, period and ovulation tracking, menstrual symptom tracking, activity profile, including steps, active minutes and calories burned, sleep stages and duration, and mood tracking. The Company is also developing a proprietary System-on-a-Chip (SoC) designed for blood pressure or continuous glucose monitoring systems. This data is delivered through a mobile app which simplifies how data is presented and turns biometric data into actionable insights that help women make manageable lifestyle changes.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Tech Stocks Rise as Market Awaits Fed Meeting and Earnings Reports
- Tech Stock Surge: Major tech firms like Apple and Microsoft saw their shares rise over 2%, propelling the S&P 500 to an all-time intraday high, indicating increased investor confidence in tech despite overall cautious market sentiment.
- Fed Policy Expectations: The market widely anticipates that the Federal Reserve will maintain its key interest rate in the 3.5% to 3.75% target range during the upcoming policy meeting, a decision that could significantly impact economic trends ahead of key tech earnings reports.
- Health Insurance Weakness: UnitedHealth (UNH) shares fell nearly 20% after the company issued a weak FY 2026 outlook, reflecting market concerns about the health insurance sector and potentially affecting investor confidence in the industry.
- Amazon's Strategic Shift: Amazon announced the closure of its Amazon Go and Amazon Fresh stores to focus on more successful formats, a move that could impact its market share and future profitability.
Continue Reading
SLB Limited Reports 5% Revenue Growth to $9.745 Billion in Q4
- Revenue Growth: SLB Limited reported fourth-quarter revenue of $9.745 billion, reflecting a 5% year-over-year increase and surpassing the analyst estimate of $9.547 billion, indicating stabilization in global upstream activities that boosts market confidence.
- Earnings Performance: While diluted GAAP earnings per share fell to 55 cents from 77 cents a year earlier, the diluted EPS excluding charges was 78 cents, exceeding the 74-cent estimate, showcasing effective cost management strategies.
- Market Reaction: Following the earnings report, SLB's stock rose by 1.37%, indicating positive investor sentiment and recognition of the company's growth potential, particularly amid a recovering global energy demand landscape.
- Industry Outlook: The improvement in SLB's performance not only enhances its competitive position within the industry but also provides a stronger financial foundation for future investments and expansions, suggesting potential for greater market share in the coming years.
Continue Reading